240 likes | 368 Views
“Randomised trials of CABG v PCI are no longer possible & cannot represent real life clinical practice”. Nick Curzen PhD FRCP FESC Southampton University Hospitals. "If a fight lasts more than 7 seconds then you are doing something wrong………… And it's usually that you are being too soft!".
E N D
“Randomised trials of CABG v PCI are no longer possible & cannot represent real life clinical practice” Nick Curzen PhD FRCP FESC Southampton University Hospitals
"If a fight lasts more than 7 seconds then you are doing something wrong………… And it's usually that you are being too soft!"
2004 data: Ludman Multi-vessel TreatmentAll Clinical Presentations The Current Perception Mean (Range)
Randomised Comparisons of PCI v CABG The Current Perception Stents used
“There’s no difference in death or MI between CABG & PCI” “We just need DES to stop restenosis”
So- the data from RCTs are relevant to our practice then? NO!: are there really no differences in mortality between CABG & PCI in the real world?
Predictors of Mortality Result of Proportional-Hazard Analyses PCI BetterCABG Better Unadjusted: PCI Covariate adjusted: Renal insufficiency Age in years Previous PCI Insulin-treated diabetes Chronic lung disease Peripheral vasc disease LVEF (10%) Non-insulin diabetes Angiographic score (10%) Left main disease Propensity adjusted: PCI No Differences? 5 4 3 2 1 0 1 2 3 4 5 Circ 2004;109:2290-2295
So- apart from the differences, the data from RCTs are relevant to our practice then? NO!: Are the study populations reallyrepresentative of real life?
17000-30000 screened!!!! REAL LIFE?
Exclusion Criteria • Previous PCI or CABG • Any total occlusion >1 month old • LVEF<30% • Overt heart failure • H/O CVA • STEMI within 7 days • Diseased saphenous veins REAL LIFE?
Patients Undergoing Angiography 100% 76% do not meet clinical inclusion/exclusion criteria Clinical Criteria 24% 18% cardiologist & surgeon cannot agree amenable to either revascularization methodology Surgeon & Interventional Cardiologist Agreement REAL LIFE? 6% 2% patients will not agree to participate Patient Consent 4% Randomized
So- apart from the differences in mortality in the real world, and the fact that the study populations were not representative of >90% of real life populations, the data from RCTs is relevant to our practicethen? NO!: Did the studies really compare complete revascularisation?
So…….. Maybe the data from these randomised studies aren’t quite so relevant to real life?
All Comers Design All Patients with 3VD/LM Heart Team (surgeon and interventionalist) amenable for both treatments options amenable for only one treatment approach Randomized Arm N=1800 (1:1) Two Registry Arms PCI All captured and followed CABG 2750 captured (750followed) vs TAXUS CABG • reasonable doubt • Goal: to define the most appropriate treatment through randomized trial methods • consensus that only one treatment option (CABG vs PCI) is appropriate • Goal: to define the pool of non randomizable patients and their outcomes
692 577 are CABG registry! 539 Overall enrollment 831 0.54 292 56
Conclusions “Randomised trials of CABG v PCI are no longer possible becausethey do not represent >90% of real life clinical practice” The extent of CABG registry arm recruitment in SYNTAX so far has already told the common sense cardiologist what he/she needs to know - regardless of the outcome of the randomised group
Acknowledgements Rod Stables Keith Dawkins Boston Scientific Corp M-C Morice Peter Ludman